[Form 4] Broadcom Inc. Insider Trading Activity

Rhea-AI Filing Summary

Broadcom (NASDAQ: AVGO) filed a Form 4 disclosing that Chief Legal & Corporate Affairs Officer Mark D. Brazeal sold 50,000 common shares on 24 Jun 2025 at a weighted-average price of $262.10, generating proceeds of roughly $13.1 million.

Following the transaction, Brazeal beneficially owns 365,956 shares, of which 336,250 are restricted stock units, implying the sale represented about 12 % of his prior holdings. The transaction was coded “S” for an open-market sale and the Rule 10b5-1 box was not indicated as checked.

Investors often monitor sizable insider dispositions by key officers as potential sentiment signals. However, Brazeal retains a substantial equity stake, limiting immediate dilution to overall insider ownership.

Positive

• None.

Negative

• Chief Legal & Corporate Affairs Officer sold 50,000 shares (~$13.1 M), reducing personal stake by ≈12 %; such sizeable open-market sales can signal diminished insider confidence.

Insights

Corporate Governance Expert

TL;DR: Large C-suite sale may flag sentiment shift

The Chief Legal Officer liquidated 50,000 shares (~$13 M), a sizeable 12 % stake reduction. Such transactions, especially when not tied to a 10b5-1 plan, can be interpreted by markets as a soft negative signal on near-term valuation or personal risk tolerance. That said, Brazeal still holds nearly 366 k shares, preserving alignment with shareholders. No accompanying disclosure of strategic change, litigation exposure, or personal tax obligations is provided, so the motivation remains opaque. While one data point does not establish a trend, investors should watch for additional insider activity to confirm whether this is an isolated liquidity event or the start of broader executive selling.

Financial Analyst

TL;DR: Sale material yet overall insider alignment intact

The dollar value and volume—$13.1 M, 50 k shares—are unquestionably material, but Brazeal still controls ~366 k shares (including RSUs), indicating continued exposure to AVGO’s upside. The sale occurred two days before filing, consistent with timely reporting. Absent other sellers or concurrent negative catalysts, I view the move as neutral to mildly negative for valuation multiples. Key watch-items: future insider selling patterns and whether options expirations or tax events explain the trade. On its own, the sale should not fundamentally alter long-term cash-flow projections or capital-return policies.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brazeal Mark David

(Last) (First) (Middle)

C/O BROADCOM INC.

3421 HILLVIEW AVENUE

(Street)

PALO ALTO CA 94304

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Broadcom Inc. [ AVGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal & Corp Affairs Ofc

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value	06/24/2025		S		50,000	D	$262.101(1)	365,956(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction executed in multiple trades at prices ranging from $262.00 to $262.26 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

2. Includes 336,250 restricted stock units.

Remarks:

	/s/ Noelle Matteson, Attorney-in-Fact for Mark Brazeal	06/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AVGO shares did Mark Brazeal sell on June 24 2025?

The Form 4 reports an open-market sale of 50,000 Broadcom shares.

What was the average sale price in Brazeal's Form 4 transaction?

The weighted-average price disclosed was $262.10 per share, with trades ranging from $262.00 to $262.26.

What percentage of his AVGO holdings did Brazeal dispose of?

The 50,000-share sale represents approximately 12 % of his pre-sale beneficial ownership.

How many AVGO shares does Mark Brazeal own after the transaction?

Post-sale, he beneficially owns 365,956 shares, including 336,250 restricted stock units.

Was Brazeal's sale executed under a Rule 10b5-1 trading plan?

The filing does not indicate that the Rule 10b5-1(c) box was checked, implying no plan was declared.